Cargando…
Caffeamide 36-13 Regulates the Antidiabetic and Hypolipidemic Signs of High-Fat-Fed Mice on Glucose Transporter 4, AMPK Phosphorylation, and Regulated Hepatic Glucose Production
This study was to investigate the antidiabetic and antihyperlipidemic effects of (E)-3-[3, 4-dihydroxyphenyl-1-(piperidin-1-yl)prop-2-en-1-one] (36-13) (TS), one of caffeic acid amide derivatives, on high-fat (HF-) fed mice. The C57BL/6J mice were randomly divided into the control (CON) group and th...
Autores principales: | Kuo, Yueh-Hsiung, Lin, Cheng-Hsiu, Shih, Chun-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130186/ https://www.ncbi.nlm.nih.gov/pubmed/25140189 http://dx.doi.org/10.1155/2014/821569 |
Ejemplares similares
-
Validation of the Antidiabetic and Hypolipidemic
Effects of Clitocybe nuda by Assessment of Glucose
Transporter 4 and Gluconeogenesis and AMPK
Phosphorylation in Streptozotocin-Induced Mice
por: Shih, Chun-Ching, et al.
Publicado: (2014) -
Antidiabetic and hypolipidemic activities of eburicoic acid, a triterpenoid compound from Antrodia camphorata, by regulation of Akt phosphorylation, gluconeogenesis, and PPARα in streptozotocin-induced diabetic mice
por: Lin, Cheng-Hsiu, et al.
Publicado: (2018) -
Pyrrolidinyl caffeamide against ischemia/reperfusion injury in cardiomyocytes through AMPK/AKT pathways
por: Lee, Shih-Yi, et al.
Publicado: (2015) -
N-(4-methoxyphenyl) caffeamide-induced melanogenesis inhibition mechanisms
por: Kuo, Yueh-Hsiung, et al.
Publicado: (2017) -
In Vitro and In Vivo Studies on Protective Action of N-Phenethyl Caffeamide against Photodamage of Skin
por: Kuo, Yueh-Hsiung, et al.
Publicado: (2015)